Abstract:Abstract Background Introduction. Type 2 glycoprotein (GP2) is a quantitatively predominant membrane protein of excretory granules of pancreatic acinar cells. In a number of studies, it has been demonstrated that this protein is the main antigen for pancreatic antibodies associated with Crohn's disease Zonulin – a protein that can reversibly increase the permeability of the intestinal wall by changing the structure of tight junctions of the lateral surfaces of intestinal epithelial cells. The determination of fecal zonulin is used for noninvasive assessment of increased intestinal permeability. Normal values of zonulin in stool (≤ 110 ng/ml) indicate the absence of damage to the villous surface of the intestinal mucosa and normal density of intercellular contacts The aim of the study was to establish the dependence of the level of type 2 glycoprotein on the level of fecal zonulin (FZ) in the feces of CD patients with exacerbation of the disease. Methods 122 patients with CD in the form of ilekolitis with exacerbation of the disease (Me age — 32 years) were examined. FZ was evaluated by ELISA (IDK ® Zonulin ELISA Kit, Immunodiagnostik AG, Germany) in ng/ml. Reference values: < 83.15 ng/ml is a variant of the norm, 83.15-110 ng/ml is an elevated level, 110 ng/ml is a high level. The level of IgG and IgA to GP2 (antibodies to glycoprotein) antigen of pancreatic centroacinar cells (Anti-GP2, IgG, IgA) was determined by ELISA. Reference values: IgG GP-2 less than 10 units/ml, Ig and GP-2 less than 5 units/ml – positive values. Results In the stool samples of CD patients during the period of exacerbation in 92 patients, an increase in FZ was detected, the average value was 333.4 ±16.9 ng/ml. In the blood samples of 87 patients with CD during the period of exacerbation, an increase in Ig A GP-2 was detected, the average value was 43.4±6.9 units/ml. In the blood samples of 107 CD patients during the period of exacerbation, an increase in Ig G GP-2 was detected, the average value was 17.1 ± 1.3 units/ml. There is a high correlation force between the concentration of FZ and the concentration of Ig A GP-2 (r-0.760) (p=0.010). There is a moderate correlation force (r-0.490) (p=0.023) between the concentration of FZ and the concentration of Ig G GP-2. Conclusion An increase in the concentration of FZ in the feces of CD patients during exacerbation significantly correlates with an increase in the concentration of Ig A GP-2 and Ig G GP-2.

Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity

Pancreatic glycoprotein 2 is a first line of defense for mucosal protection in intestinal inflammation

GP2-expressing cells: a new guardian with divergent functions in the intestine, eyes, and nose

Fecal glycoprotein 2 is a marker of gut microbiota dysbiosis and systemic inflammation

[Progress in the Role of Intestinal Goblet Cells in Intestinal Immune Regulation].

Wheat Germ Glycoprotein Regionally Modulates Immunosuppressed Mouse Intestinal Immunity Function from Early Life to Adulthood.

The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses

Innate Immunity of the Gut: Mucosal Defense in Health and Disease

P338 The dependence of the level of Glycoprotein type 2 on the level of Zonulin in Crohn's disease

Modulating the gut microbiota is involved in the effect of low-molecular-weight Glycyrrhiza polysaccharide on immune function

The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis

Phage Display-Derived Ligand for Mucosal Transcytotic Receptor GP-2 Promotes Antigen Delivery to M Cells and Induces Antigen-Specific Immune Response.

Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease

Small Intestinal Goblet Cells Control Humoral Immune Responses and Mobilization During Enteric Infection

PGLYRP-1 mediated intracellular peptidoglycan detection promotes mucosal protection

The role of glycans in health and disease: Regulators of the interaction between gut microbiota and host immune system

The relationship between intestinal goblet cells and the immune response

Microbial-gut interactions in health and disease. Mucosal immune responses

Guardians of the gut: influence of the enteric nervous system on the intestinal epithelial barrier

Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis

IgGFc-binding protein and MUC2 mucin produced by colonic goblet-like cells spatially interact non-covalently and regulate wound healing